Advertisement
Screener

Alaunos Therapeutics, Inc. (TCRT) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

1.5 / 5 stars · 19/64 Roast Me

Add as a preferred source on Google

Alaunos Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Alaunos Therapeutics, Inc. (TCRT) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 748.40 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-14

  • Alaunos Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 697.57K shares, a 871.65% increase year-over-year.
  • Alaunos Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 71.79K shares, a 57.86% decline year-over-year.
  • Alaunos Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 170.38K shares, a 93.12% decline year-over-year.
  • Alaunos Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 2.48M shares, a 92.90% decline year-over-year.
  • Alaunos Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 699.40K shares, a 1069.79% increase from fiscal 2024.
  • Alaunos Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 59.79K shares, a 68.83% decline from fiscal 2023.
  • Alaunos Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 191.83K shares, a 91.60% decline from fiscal 2022.
  • Alaunos Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 2.28M shares, a 93.44% decline from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-30748.40K shares
10-Q · filed 2026-08-14
2026-03-31697.57K shares
10-Q · filed 2026-05-15
2025-12-31699.40K shares
10-K · filed 2026-03-31
2025-09-30394.30K shares
10-Q · filed 2025-11-14
2025-06-30337.08K shares
10-Q · filed 2026-08-14
2025-03-3171.79K shares
10-Q · filed 2026-05-15
2024-12-3159.79K shares
10-K · filed 2026-03-31		59.79K shares
10-K · filed 2025-03-31
2024-09-3059.79K shares
10-Q · filed 2025-11-14
2024-06-30175.48K shares
10-Q · filed 2025-08-14
2024-03-31170.38K shares
10-Q · filed 2025-05-15		1.70M shares
10-Q · filed 2024-05-15
2023-12-31191.83K shares
10-K · filed 2025-03-31		1.92M shares
10-K · filed 2024-04-01
2023-09-30238.51K shares
10-Q · filed 2024-11-14		35.78M shares
10-Q · filed 2023-11-14
2023-06-30247.92K shares
10-Q · filed 2024-08-14		37.19M shares
10-Q · filed 2023-08-14
2023-03-312.48M shares
10-Q · filed 2024-05-15		37.13M shares
10-Q · filed 2023-05-10
2022-12-312.28M shares
10-K · filed 2024-04-01		34.27M shares
10-K · filed 2023-03-07
2022-09-3034.49M shares
10-Q · filed 2023-11-14
2022-06-3034.17M shares
10-Q · filed 2023-08-14
2022-03-3134.89M shares
10-Q · filed 2023-05-10
2021-12-3134.82M shares
10-K · filed 2023-03-07
2021-09-3035.39M shares
10-Q · filed 2022-11-14
2021-06-3033.99M shares
10-Q · filed 2022-08-15
2021-03-3134.55M shares
10-Q · filed 2022-05-16
2020-12-3130.48M shares
10-K · filed 2022-03-30
2020-09-3031.00M shares
10-Q · filed 2021-11-08
2020-06-3031.05M shares
10-Q · filed 2021-08-13
2020-03-3131.48M shares
10-Q · filed 2021-05-06
2019-12-3131.12M shares
10-K · filed 2021-03-01		30.09M shares
10-K · filed 2020-03-02
2019-09-3026.47M shares
10-Q · filed 2020-11-05
2019-06-3026.07M shares
10-Q · filed 2020-08-06
2019-03-3126.48M shares
10-Q · filed 2020-05-07		25.98M shares
10-Q · filed 2019-05-08
2018-12-3125.20M shares
10-K · filed 2021-03-01		24.70M shares
10-K · filed 2019-03-05
2018-09-3058.32M shares
10-Q · filed 2019-11-07
2018-06-3047.26M shares
10-Q · filed 2019-08-08
2018-03-3140.51M shares
10-Q · filed 2019-05-08
2017-12-3140.30M shares
10-K · filed 2020-03-02
2017-09-3027.85M shares
10-Q · filed 2018-11-09		27.35M shares
10-Q · filed 2017-11-06
2017-06-3028.16M shares
10-Q · filed 2018-08-08
2017-03-3125.73M shares
10-Q · filed 2018-05-10
2016-12-3125.61M shares
10-K · filed 2019-03-05
2016-09-3027.25M shares
10-Q · filed 2017-11-06
2016-06-304.67M shares
10-Q · filed 2017-07-31
2016-03-314.99M shares
10-Q · filed 2017-05-01
2015-12-315.07M shares
10-K · filed 2018-03-01
2015-09-304.78M shares
10-Q · filed 2016-11-09
2015-06-304.67M shares
10-Q · filed 2016-08-09
2015-03-316.02M shares
10-Q · filed 2016-05-10
2014-12-316.65M shares
10-K · filed 2017-02-16
2014-09-3014.31M shares
10-Q · filed 2015-11-02
2014-06-3016.83M shares
10-Q · filed 2015-08-10
2014-03-3117.00M shares
10-Q · filed 2015-05-07
2013-12-3117.64M shares
10-K · filed 2016-02-24
2013-09-3016.55M shares
10-Q · filed 2014-10-30
2013-06-3017.43M shares
10-Q · filed 2014-08-07
2013-03-3118.49M shares
10-Q · filed 2014-05-08
2012-12-3119.08M shares
10-K · filed 2015-02-26
2012-09-3017.48M shares
10-Q · filed 2013-10-22
2012-06-3017.70M shares
10-Q · filed 2013-08-08
2012-03-3117.90M shares
10-Q · filed 2013-05-07
2011-12-3119.21M shares
10-K · filed 2014-03-03
2011-09-3018.46M shares
10-Q · filed 2012-11-08
2011-06-3018.29M shares
10-Q/A · filed 2012-08-28
2010-12-3120.83M shares
10-K · filed 2013-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Genprex, Inc. (GNPX)United States$0.003B-0.02
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
Sunshine Biopharma Inc. (SBFM)$0.003B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Aptevo Therapeutics Inc. (APVO)United States$0.003B
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
Advertisement